Founded Year

2006

Stage

Reverse Merger | IPO

Total Raised

$93.42M

Market Cap

0.13B

Stock Price

0.56

About Asensus Surgical

Asensus Surgical is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today's value-based healthcare environment. The company is focused on the commercialization of the Senhance™ Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The Company also developed the SurgiBot System, a single-port, robotically enhanced laparoscopic surgical platform.

Asensus Surgical Headquarter Location

635 Davis Drive Suite 300

Morrisville, North Carolina, 27560,

United States

919-765-8400

Asensus Surgical's Product Videos

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Asensus Surgical's Products & Differentiation

See Asensus Surgical's products and how their products differentiate from alternatives and competitors

  • Senhance Surgical System

    The Senhance® Surgical System is the first of its kind and the only digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and improved patient outcomes through machine learning. The Senhance Surgical System is designed to support hospitals and help surgeons thrive in today’s healthcare landscape. This digital laparoscopic platform removes the economic limitations of current robotic systems with standard reusable instruments and an open-platform architecture strategy that enables hospitals to leverage existing technology investments. That keeps time and cost-per-procedure comparable to traditional laparoscopy, so that the benefits of robotics can reach more patients, in more care settings, for a greater variety of procedures.

    Differentiation

    Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization; and is the first platform to offer… 

Expert Collections containing Asensus Surgical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Asensus Surgical is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,941 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

Asensus Surgical Patents

Asensus Surgical has filed 109 patents.

The 3 most popular patent topics include:

  • Surgery
  • Surgical instruments
  • Surgical robots
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/9/2018

5/3/2022

Surgical instruments, Surgery, Robot kinematics, Surgical removal procedures, Robotic manipulators

Grant

Application Date

5/9/2018

Grant Date

5/3/2022

Title

Related Topics

Surgical instruments, Surgery, Robot kinematics, Surgical removal procedures, Robotic manipulators

Status

Grant

Latest Asensus Surgical News

Asensus Surgical Announces Sale of Senhance Robotic System

Aug 4, 2022

Senhance System to be placed at hospital in the Commonwealth of Independent States Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery, announced that a Senhance Surgical System was sold to the Company’s distribution partner, and will be placed in a hospital in the Commonwealth of Independent States (CIS) region. “We are excited to be partnering with yet another institution to initiate a Senhance program to deliver better patient outcomes,” said Anthony Fernando , Asensus Surgical President and CEO. “With the combination of unique instrumentation, including 3mm and articulation, advanced safety features such as haptic feedback, and the industry’s only intelligent Artificial Intelligence platform, Senhance provides the opportunity to revolutionize a surgical team’s capabilities when performing laparoscopic procedures.’’ Asensus Surgical’s technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization, and is the first platform to offer 3mm instruments (the smallest instrument available in the world on a robotic surgical platform). The ISU enables machine vision-driven control of the camera for a surgeon by responding to commands and recognizing certain objects and locations in the surgical field, and allows a surgeon to change the visualized field of view using the movement of their instruments. Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare

Asensus Surgical Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Asensus Surgical Rank

  • When was Asensus Surgical founded?

    Asensus Surgical was founded in 2006.

  • Where is Asensus Surgical's headquarters?

    Asensus Surgical's headquarters is located at 635 Davis Drive, Morrisville.

  • What is Asensus Surgical's latest funding round?

    Asensus Surgical's latest funding round is Reverse Merger.

  • How much did Asensus Surgical raise?

    Asensus Surgical raised a total of $93.42M.

  • Who are the investors of Asensus Surgical?

    Investors of Asensus Surgical include SafeStitch Medical, Synergy Life Science Partners, SV Health Investors, InterSouth Partners, Quaker BioVentures and 6 more.

  • Who are Asensus Surgical's competitors?

    Competitors of Asensus Surgical include ACTIV Surgical, Yuanhua Intelligent, Robocath, Vicarious Surgical, MicroPort Medical Robot, Quantum Surgical, PROCEPT BioRobotics, Neuralink, CMR Surgical, Neocis and 29 more.

  • What products does Asensus Surgical offer?

    Asensus Surgical's products include Senhance Surgical System.

  • Who are Asensus Surgical's customers?

    Customers of Asensus Surgical include US Hospital.

You May Also Like

CMR Surgical Logo
CMR Surgical

CMR Surgical is a surgical robotics company developing universal robotic systems for minimal access surgery. The company's vision is to make minimal access (or keyhole) surgery universally accessible and affordable by significantly expanding the range of procedures that can be performed robotically.

A
ACTIV Surgical

Activ is a developer of software to augment surgeons. It develops an AI/ML platform called ActivEdge, which is designed to provide real-time intelligence and visualization to surgeons. The company was founded in 2017 and is based in Boston, Massachusetts.

Neocis Logo
Neocis

Neocis is a privately held company focused on improving health care through robotic assistance, manufactures and markets YOMI, a robot-assisted surgical platform for the dental industry.

Neuralink Logo
Neuralink

Neuralink develops ultra high bandwidth brain-machine interfaces to connect humans and computers.

E
EDDA Technology

EDDA Technology specializes in imaging-guided cancer treatment services. The company provides computer-assisted radiology, surgery solutions and imaging analysis.

Promaxo Logo
Promaxo

Promaxo develops an office-based, portable MRI with cellular spatial resolution​, and​ real​-​time targeted ​biopsy and treatment ​tools​​ for the urology market. The company's current focus is on ​transforming ​prostate cancer disease management.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.